However, in the subgroup analysis of IGF-1's effect on unfavorable outcomes after ischemic stroke, IGF-1 was significantly associated with poor prognosis more than 1 year after stroke onset (RR = 3.33, 95% CI = 2.19–5.05, I2 = 0%, random-effects model). The gene discussed is IGF1; the disease is stroke disorder.